CN118201590A - Cosmetic product - Google Patents

Cosmetic product Download PDF

Info

Publication number
CN118201590A
CN118201590A CN202280073325.5A CN202280073325A CN118201590A CN 118201590 A CN118201590 A CN 118201590A CN 202280073325 A CN202280073325 A CN 202280073325A CN 118201590 A CN118201590 A CN 118201590A
Authority
CN
China
Prior art keywords
cosmetic
component
formula
carbon atoms
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280073325.5A
Other languages
Chinese (zh)
Inventor
李石
铃木育浩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Publication of CN118201590A publication Critical patent/CN118201590A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/87Polyurethanes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

[ Problem ] to provide a cosmetic having excellent feel in use. [ solution ] A cosmetic comprising: (A) a cyclic carboxamide derivative having a specific structure or a salt thereof, (B) a hydrophobically modified polyether polyurethane and (C) water.

Description

Cosmetic product
Technical Field
The present invention relates to a cosmetic composition comprising a cyclic carboxamide derivative having a specific structure or a salt thereof and a hydrophobically modified polyether polyurethane.
Background
Since hydrophobically modified polyether polyurethanes are known as viscosity modifiers (also referred to as associative thickeners) having little temperature dependence of viscosity, a unique film feel is obtained by blending the thickener, and therefore, cosmetics blended with hydrophobically modified polyether polyurethanes are commercially available in a large number. For example, a cosmetic product having improved feel in use, which contains a hydrophobically modified polyether polyurethane, nicotinamide and a specific surfactant, has been proposed (patent document 1). Such cosmetics are required to have a more excellent feel in use, and there is room for further improvement in feel in use.
On the other hand, it is known that a cyclic carboxamide derivative has an anti-wrinkle effect and a pigmentation-suppressing effect, and it is proposed to blend a cyclic carboxamide derivative into cosmetics and the like (patent document 2).
Prior art literature
Patent literature
Patent document 1: japanese patent laid-open No. 2021-172610
Patent document 2: international publication 2011/040496
Disclosure of Invention
According to the studies by the present inventors, it is found that when a cyclic carboxamide derivative is used in cosmetics, the fusion with the skin during application tends to be slow, and the mixture tends to be sticky after application. The present inventors have found that by using a cosmetic comprising a combination of a specific cyclic carboxamide derivative and a hydrophobically modified polyether polyurethane, surprisingly, skin-friendly feel, viscosity can be improved and at the same time more excellent feel in use can be achieved. The present invention is based on these findings.
According to the present invention, the following invention is provided.
[1] A cosmetic product comprising:
(A) A cyclic carboxamide derivative represented by formula (a) or a salt thereof;
(B) Hydrophobically modified polyether polyurethane; and
(C) The water is used as the water source,
(In the formula (a),
R a is a hydrocarbon group having 1 to 6 carbon atoms optionally substituted with a hydroxyl group, or a hydrogen atom,
X is-CH 2 -or-N (R 1) -, where R 1 is a C1-6 hydrocarbon group optionally substituted with a hydroxyl group, or is a hydrogen atom, and
N is an integer of 1 to 3. )
[2] The cosmetic according to [1], wherein in the formula (a) of the component (A),
R a is hydroxyalkyl of 1-3 carbon atoms,
X is-CH 2 -or-NH-, and
N is 1.
[3] The cosmetic according to [1] or [2], wherein the component (A) is 1- (2-hydroxyethyl) -2-imidazolidinone.
[4] The cosmetic according to any one of [1] to [3], wherein the blending amount of the component (A) is 0.1 to 5% by mass relative to the total amount of the cosmetic.
[5] The cosmetic according to any one of [1] to [4], wherein the component (B) is represented by the formula (B).
(In the formula (b),
R b1 is alkyl with 2-36 carbon atoms,
R b2 and R b4 are each independently a phenylethene or an alkylene group having 2 to 4 carbon atoms,
R b3 is an alkylene group having 1 to 10 carbon atoms optionally having a urethane bond,
R b5 is alkyl with 8-36 carbon atoms,
M is a number of 2 or more,
H is a number of 1 or more,
K is a number from 1 to 500, and
J is a number of 1 to 200. )
[6] The cosmetic according to any one of [1] to [5], wherein the component (B) is PEG-240/HDI copolymer bis-decyl tetradecyl polyether-20 ether.
[7] The cosmetic according to any one of [1] to [6], wherein the blending amount of the component (B) is 0.5 to 2.3% by mass relative to the total amount of the cosmetic.
[8] The cosmetic according to any one of [1] to [6], wherein the blending amount of the component (B) is 0.1 to 5% by mass relative to the total amount of the cosmetic.
[9] The cosmetic according to any one of [1] to [8], wherein the viscosity of the cosmetic is 2000 to 80000 mPas measured at 30 ℃ using a B-type rotational viscometer.
[10] The cosmetic according to any one of [1] to [9], which is a gel cosmetic.
According to the present invention, a cosmetic excellent in use feeling can be provided. In particular, the cream has good fusion with skin during application, is not sticky after application, and also gives mellow feeling.
Detailed Description
The present invention relates to a cosmetic composition comprising (A) a cyclic carboxamide derivative having a specific structure or a salt thereof, (B) a hydrophobically modified polyether polyurethane, and (C) water.
(A) Cyclic carboxamide derivative or salt thereof
The cosmetic of the present invention comprises a cyclic carboxamide derivative represented by the formula (a) or a salt thereof (hereinafter, sometimes referred to as component (a)), and other components are also similarly present.
In the formula (a), the amino acid sequence of the formula (a),
R a is a hydrocarbon group having 1 to 6 carbon atoms optionally substituted with a hydroxyl group, or a hydrogen atom,
X is-CH 2 -or-N (R 1) -, where R 1 is a C1-6 hydrocarbon group optionally substituted with a hydroxyl group, or is a hydrogen atom, and
N is an integer of 1 to 3.
The hydrocarbon group is not particularly limited, and may be, for example, an alkyl group, a cycloalkyl group, an alkenyl group, an alkynyl group, a cycloalkylalkyl group, a haloalkyl group, an alkoxyalkyl group, or an alkoxycarbonylalkyl group, and is preferably an alkyl group.
In a preferred embodiment, in the formula (a) of the component (A),
R a is hydroxyalkyl of 1-3 carbon atoms,
X is-CH 2 -or-NH-, and
N is 1.
Specific examples of the cyclic carboxamide derivative represented by formula (a) include the following.
(A) The most preferred ingredient is 1- (2-hydroxyethyl) -2-imidazolidinone.
(A) The component (a) may be a salt of a cyclic carboxamide derivative represented by the formula (a). The salt is not particularly limited as long as it is pharmaceutically acceptable, and may be an inorganic salt or an organic salt. Examples of the inorganic salts include hydrochloride, sulfate, phosphate, hydrobromide, sodium salt, potassium salt, magnesium salt, calcium salt, magnesium salt, and ammonium salt. Examples of the organic salt include acetate, lactate, maleate, fumarate, tartrate, methanesulfonate, p-toluenesulfonate, triethanolamine salt, and amino acid salt.
(A) The components may be blended in 1 or 2 or more. (A) The amount of the component (A) to be blended is preferably 0.1 to 5% by mass, more preferably 0.3 to 3% by mass, and still more preferably 1 to 2% by mass, based on the total amount of the cosmetic.
(B) Hydrophobically modified polyether polyurethanes
The cosmetic of the present invention comprises (B) a hydrophobically modified polyether polyurethane. (B) The components are also called associative thickeners and associative polymers.
In a preferred embodiment, the component (B) is represented by the formula (B).
In the formula (b), the amino acid sequence of the formula (b),
R b1 is an alkyl group having 2 to 36 carbon atoms, preferably an alkyl group having 2 to 4 carbon atoms.
R b2 and R b4 are each independently a phenylethene or an alkylene group having 2 to 4 carbon atoms, preferably an alkyl group having 2 to 4 carbon atoms.
R b3 is an alkylene group having 1 to 10 carbon atoms optionally having a urethane bond.
R b5 is an alkyl group having 8 to 36 carbon atoms, preferably an alkyl group having 12 to 24 carbon atoms.
M is a number of 2 or more, preferably 2.
H is a number of 1 or more, preferably 1.
K is a number of 1 to 500, preferably a number of 100 to 300.
J is a number of 1 to 200, preferably 10 to 100.
(B) The component is preferably PEG-240/HDI copolymer di-decyl tetradecyl polyether-20 ether. As a commercial product, for example, "ADEKA NOL GT-700" (manufactured by ADEKA Co., ltd.).
(B) The components may be blended in 1 or 2 or more. (B) The blending amount of the component is preferably 0.5 to 2.3% by mass, more preferably 1 to 1.8% by mass, based on the total amount of the cosmetic. Within this range, the unique film feel of component (B) can be further obtained. In the present specification, the film feel means: when applied to the skin, the soft coating film gently covers the skin to protect the touch.
(C) Water and its preparation method
The cosmetic of the present invention comprises (C) water. As the water, water used in cosmetics, quasi drugs, and the like can be used, and purified water, ion-exchanged water, tap water, and the like can be used, for example.
The amount of water to be blended is preferably 40 to 98% by mass, more preferably 60 to 90% by mass, based on the total amount of the cosmetic composition of the present invention.
The cosmetic of the present invention may contain other optional ingredients within a range that does not impair the effects of the present invention. Examples of other optional components include an aqueous solvent, a thickener (excluding component (B)), a humectant, an oil component, an ultraviolet absorber, a pharmaceutical agent, a chelating agent, a preservative, an antioxidant, a powder, a perfume, a colorant, a coloring agent, and the like, and can be suitably blended depending on the form and use of the cosmetic.
Examples of the aqueous solvent include lower alcohols such as ethanol, 1-propanol, 2-propanol, isobutanol, and t-butanol.
Examples of the thickener include acacia, carrageenan, karaya, tragacanth, carob gum, quince seed (quince), casein, dextrin, gelatin, sodium pectate, sodium alginate, methyl cellulose, ethyl cellulose, CMC, hydroxyethyl cellulose, hydroxypropyl cellulose, PVA, PVM, PVP, sodium polyacrylate, carboxyvinyl polymer (carbomer), dimethylacrylamide/sodium acryloyldimethyltaurate cross-linked polymer, acrylamide/ammonium VP copolymer, acrylamide dimethyltaurate/behenate-25 methacrylate cross-linked polymer, sodium acrylate/sodium acryloyldimethyltaurate copolymer, locust bean gum, guar gum, acid bean gum, dialkyl dimethyl ammonium cellulose sulfate, xanthan gum, aluminum magnesium silicate, bentonite, hectorite, aluminum magnesium silicate (VEEGUM), laponite, silicic anhydride, and the like.
Examples of the humectant include polyethylene glycol, propylene glycol, dipropylene glycol (DPG), glycerin, 1, 3-butanediol, chondroitin sulfate, hyaluronic acid, glycosaminoglycan sulfate, caronic acid, atelocollagen, cholesterol hydroxystearate, sodium lactate, bile acid salt, dl-pyrrolidone carboxylate, alkylene oxide derivative, short chain soluble collagen, diglycerol (EO) PO adduct, and the like. In the present specification, EO represents ethylene oxide, and PO represents propylene oxide.
The oil component is not particularly limited, and various kinds of oil components widely used in cosmetics, whether solid oil components or liquid oil components, may be blended.
The solid oil component is an oil component which is usually used in cosmetics and is solid or semisolid at room temperature. Examples of such oil components include solid oils such as cocoa butter, coconut oil, horse oil, hydrogenated coconut oil, palm oil, tallow, sheep oil, hardened tallow, palm kernel oil, lard, bovine bone oil, nux-vomica oil, hardened oil, tallow, nux-vomica oil, hydrogenated castor oil, and the like; waxes such as beeswax, candelilla wax, cotton wax, carnauba wax, bayberry wax, shellac wax, spermaceti wax, montan wax, rice husk wax, lanolin, kapok wax, acetylated lanolin, sugarcane wax, isopropyl lanolate, hexyl laurate, hydrogenated lanolin, jojoba wax, hard lanolin, shellac wax, POE lanolin alcohol ether, POE lanolin alcohol acetate, POE cholesterol ether, POE hydrogenated lanolin alcohol ether; hydrocarbon waxes such as polyethylene wax, paraffin wax, ceresin, petrolatum, microcrystalline wax, lunacera, etc.; fatty acid glycerol ethers such as monostearyl glycerol ether (batyl alcohol); fatty acid glycerides such as acetylglyceride and triglyceride (2-heptylundecanoate), and 1 or 2 or more of these may be used in combination.
Liquid oil refers to oil that is liquid at room temperature, which is commonly used in cosmetics. Examples of such oil include liquid oils such as avocado oil, evening primrose oil, camellia seed oil, turtle oil, macadamia rima (MACADAMIA INTEGRIFOLIA) seed oil, sunflower (HELIANTHUS ANNUUS) seed oil, sweet almond (PRUNUS AMYGDALUSDULCIS) oil, corn oil, mink oil, olive (OLEA EUROPAEA) fruit oil, rapeseed oil, egg oil, sesame oil, peach kernel oil, wheat germ oil, camellia oil, castor oil, linseed oil, safflower oil, cottonseed oil, perilla oil, soybean oil, peanut oil, tea seed oil, torreya oil, rice bran oil, jatropha oil, japan tung oil, jojoba seed oil, and germ oil; cetyl octanoate, ethyl cetyl 2-acetate, cetyl dimethyloctanoate, ethyl laurate, hexyl laurate, isopropyl myristate, 2-hexyldecyl myristate, myristyl myristate, octyldodecyl myristate, isopropyl palmitate, 2-ethylhexyl palmitate, isocetyl palmitate, 2-heptylundecyl palmitate, butyl stearate, isocetyl isostearate, decyl oleate, dodecyl oleate, oil oleate, lactic myristate, lactic cetyl lactate, diisostearyl malate, cholesterol 12-hydroxystearate, methyl castor oil fatty acid, 2-ethylhexyl succinate, and ester oils such as diisobutyl adipate, 2-hexyldecyl adipate, di (heptyl undecyl) adipate, diisopropyl sebacate, di (2-ethylhexyl) sebacate, ethylene glycol bis (2-ethylhexanoate), neopentyl glycol dicaprate, neopentyl glycol di (ethylhexanoate), acetylglyceride, di (2-heptyl undecanoate), trioctanoate, tri (2-ethylhexanoate), trimyristate, triisopalmitate, tri (2-heptyl undecanoate), trimethylolpropane tri (2-ethylhexanoate), trimethylolpropane triisostearate, pentaerythritol tetraoctanoate, pentaerythritol tetra-2-ethylhexanoate, and the like; hydrocarbon oils such as liquid paraffin, squalene, pristane, polybutene, and the like; silicone oils such as chain polysiloxanes such as dimethylpolysiloxane, polymethylphenylsiloxane, diphenylpolysiloxane, cyclic polysiloxanes such as octamethyl cyclotetrasiloxane, cyclopentadimethicone, and dodecamethyl cyclosiloxane, and various modified polysiloxanes such as amino modified polysiloxanes, polyether modified polysiloxanes, alkyl modified polysiloxanes, and fluorine modified polysiloxanes, and 1 or 2 or more of these may be used in combination.
Examples of the ultraviolet absorber include benzoic acid-based ultraviolet absorbers such as p-aminobenzoic acid; an anthranilic acid-based ultraviolet absorber such as methyl anthranilate; salicylic acid ultraviolet absorbers such as octyl salicylate; cinnamic acid ultraviolet absorbers such as isopropyl p-methoxycinnamate and octyl p-methoxycinnamate; pyridazine derivatives such as dimorpholinopyridazinone; benzoyl methane derivatives such as 4-methoxy-4' -tert-butyldibenzoylmethane; camphor derivatives such as 3- (4' -methylbenzylidene) -D, l-camphor, 3-benzylidene-D, l-camphor and the like; benzotriazole derivatives such as 2,2' -hydroxy-5-methylphenyl benzotriazole, 2- (2 ' -hydroxy-5 ' -tert-octylphenyl) benzotriazole and 2- (2 ' -hydroxy-5 ' -methylphenyl benzotriazole, 2-phenyl-5-methylbenzoxazole, dibenzhydrazine, diphenylaminomethane, 5- (3, 3-dimethyl-2-norbornene) -3-pentan-2-one, and the like.
Examples of the pharmaceutical agents include ascorbic acid (vitamin C), tranexamic acid, kojic acid, ellagic acid, nicotinic acid, arbutin, alkoxysalicylic acid, glycyrrhizic acid, tocopherol, retinol, and salts or derivatives of these (for example, sodium L-ascorbate, magnesium L-ascorbate, L-ascorbyl glucoside, 2-O-ethyl-L-ascorbic acid, 3-O-ethyl-L-ascorbic acid, 4-methoxysalicylate, 4-methoxysalicylic acid potassium salt, dipotassium glycyrrhizinate, stearyl glycyrrhetinate, nicotinamide, tocopheryl acetate, retinol palmitate, and the like). In addition, various extracts and the like may be blended, but the cosmetic of the present invention also includes the following means: does not contain flavonoid-containing plant extract and humus extract.
Examples of the chelating agent include citramalic acid, matsutake acid, glyceric acid, shikimic acid, sabinol, gallic acid, tannic acid, caffeic acid, ethylenediamine tetraacetic acid, diethylenetriamine pentaacetic acid, phytic acid, polyphosphoric acid, metaphosphoric acid, and analogues, alkali metal salts, and carboxylic acid esters thereof.
Examples of the preservative include parabens such as methylparaben, ethylparaben and butylparaben, benzoic acid, salicylic acid, sorbic acid, parachlorometacresol, hexachlorophene, benzalkonium chloride, chlorhexidine, trichlorocarbanilide, photosensitizers, phenoxyethanol, and the like.
Examples of the antioxidant include α -tocopherol and carotenoid.
The cosmetic of the present invention can be widely applied to the following forms: basic cosmetics such as medicines, quasi-medicines (ointments, etc.), facial cleanser, astringent, emulsion, cream, gel, essence (skin-care liquid), dressing, facial mask, etc.; make-up cosmetics such as foundations and lipsticks; sun care commodities such as sunscreens; aromatic cosmetics; body cosmetics, and the like.
In a preferred embodiment, the composition is used as a skin cosmetic in view of the feel of use when applied to the skin. More preferably, the cosmetic of the present invention is a gel cosmetic.
The viscosity of the cosmetic of the present invention is preferably 2000 to 80000 mPas, more preferably 4000 to 20000 mPas, as measured at 30℃using a B-type rotational viscometer.
Examples
The present invention will be specifically described with reference to the following examples, but the present invention is not limited to these examples. The content is expressed as mass% relative to the total amount unless otherwise indicated.
Examples 1 to 5 and comparative examples 1 to 4
Cosmetics of examples 1 to 5 and comparative examples 1 to 4 were prepared by blending as shown in Table 1. The numerical values of the respective components in the table represent mass%.
The viscosity of the obtained cosmetics is shown in Table 1. The viscosity was measured using a type B viscometer (30 ℃). The viscosity of comparative example 1 was not measured because it was liquid, and was 1,000 mPas or less.
The cosmetics of examples 1 to 5 and comparative examples 2 to 4 were gel-like, and the cosmetic of comparative example 1 was liquid.
TABLE 1
The cosmetics prepared above were applied to the skin by 10 panelists 10, and evaluated for "presence or absence of stickiness after application", "merits of fusion during application", and "body feeling after application". Based on the evaluation of each panelist, a determination was made according to the following criteria. The results obtained are shown in Table 1.
[ Sticky Presence or not after application ]
A: more than 7 of the 10 panelists had responses that were not sticky.
B: more than 4 and less than 6 of the 10 panelists had no sticky responses.
C: more than 1 and less than 3 of the 10 panelists had no sticky responses.
D: all responses from 10 panelists were sticky.
[ Fusion in smearing ]
A: more than 7 of the 10 panellists fused well.
B: more than 4 and less than 6 of the 10 panellists fused well.
C: more than 1 and less than 3 of the 10 panelists fused well.
D: all responses of the 10 panelists fused poorly.
[ Mellow feeling after application ]
A: more than 7 of the 10 panelists had a mellow response.
B: more than 4 and less than 6 of the 10 panelists had a mellow feeling in response.
C: more than 1 and less than 3 of the 10 panelists had a mellow feeling in response.
D: all 10 panelists responded to the skin with poor body feeling.

Claims (10)

1. A cosmetic product comprising:
(A) A cyclic carboxamide derivative represented by formula (a) or a salt thereof;
(B) Hydrophobically modified polyether polyurethane; and
(C) The water is used as the water source,
In the formula (a), the amino acid sequence of the formula (a),
R a is a hydrocarbon group having 1 to 6 carbon atoms optionally substituted with a hydroxyl group, or a hydrogen atom,
X is-CH 2 -or-N (R 1) -, where R 1 is a C1-6 hydrocarbon group optionally substituted with a hydroxyl group, or is a hydrogen atom, and
N is an integer of 1 to 3.
2. The cosmetic according to claim 1, wherein in the formula (a) of the component (A),
R a is hydroxyalkyl of 1-3 carbon atoms,
X is-CH 2 -or-NH-, and
N is 1.
3. The cosmetic according to claim 1 or 2, wherein component (a) is 1- (2-hydroxyethyl) -2-imidazolidinone.
4. The cosmetic according to claim 1 or 2, wherein the component (a) is incorporated in an amount of 0.1 to 5% by mass based on the total amount of the cosmetic.
5. The cosmetic according to claim 1 or 2, wherein the component (B) is represented by the formula (B),
In the formula (b), the amino acid sequence of the formula (b),
R b1 is alkyl with 2-36 carbon atoms,
R b2 and R b4 are each independently a phenylethene or an alkylene group having 2 to 4 carbon atoms,
R b3 is an alkylene group having 1 to 10 carbon atoms optionally having a urethane bond,
R b5 is alkyl with 8-36 carbon atoms,
M is a number of 2 or more,
H is a number of 1 or more,
K is a number from 1 to 500, and
J is a number of 1 to 200.
6. The cosmetic according to claim 1 or2, wherein the component (B) is PEG-240/HDI copolymer bis-decyltetradecylether-20 ether.
7. The cosmetic according to claim 1 or 2, wherein the blending amount of the component (B) is 0.5 to 2.3% by mass relative to the total amount of the cosmetic.
8. The cosmetic according to claim 1 or 2, wherein the blending amount of the component (B) is 0.1 to 5% by mass relative to the total amount of the cosmetic.
9. The cosmetic according to claim 1 or 2, wherein the viscosity of the cosmetic is 2000 to 80000 mPa-s as measured at 30 ℃ using a B-type rotational viscometer.
10. The cosmetic according to claim 1 or 2, which is a gel cosmetic.
CN202280073325.5A 2021-12-03 2022-11-18 Cosmetic product Pending CN118201590A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021-196753 2021-12-03
JP2021196753 2021-12-03
PCT/JP2022/042808 WO2023100682A1 (en) 2021-12-03 2022-11-18 Cosmetic

Publications (1)

Publication Number Publication Date
CN118201590A true CN118201590A (en) 2024-06-14

Family

ID=86612094

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280073325.5A Pending CN118201590A (en) 2021-12-03 2022-11-18 Cosmetic product

Country Status (2)

Country Link
CN (1) CN118201590A (en)
WO (1) WO2023100682A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011040496A1 (en) * 2009-09-30 2011-04-07 株式会社資生堂 Heparanase activity inhibitor
JP2012067024A (en) * 2010-09-22 2012-04-05 Shiseido Co Ltd Skin care preparation for external use
JP2019014709A (en) * 2017-07-07 2019-01-31 ポーラ化成工業株式会社 Skin care composition
JP2021172610A (en) * 2020-04-24 2021-11-01 株式会社 資生堂 Cosmetic

Also Published As

Publication number Publication date
WO2023100682A1 (en) 2023-06-08

Similar Documents

Publication Publication Date Title
JP4608584B1 (en) Skin preparation
JPH1053510A (en) Composition for external use
JP2008231010A (en) External preparation for skin
WO2002056852A1 (en) Cosmetics
WO2012127852A1 (en) Solid cosmetic
JP4046313B2 (en) Water-in-oil emulsified composition and emulsified cosmetic using the same
KR102359729B1 (en) Cosmetic Composition for Reducing Stickiness and Improving Transparency of Emulsion Formulation
US20070009458A1 (en) Lipophilic personal care composition
JP4601031B2 (en) W / O / W emulsified cosmetics
CA2613296A1 (en) Lipophilic personal care composition
JP2005281133A (en) Skin care preparation for external use
US20070009457A1 (en) Lipophilic personal care composition
CN115135296A (en) Oil-in-water type emulsion cosmetic
CN118201590A (en) Cosmetic product
JPH1149655A (en) Skin lotion
JP2011006372A (en) Beauty treatment
WO2021215423A1 (en) Cosmetic preparation
TW202203894A (en) Oil-in-water type cosmetic emulsion preparation
KR101815127B1 (en) Thermo-sensitive color cosmetic composition and the method of producing the same
JP2005281135A (en) Skin care preparation for external use
EP4031096A1 (en) Gel composition with high oil content, the preparation method and the use of the same
CN117999060A (en) Cosmetic product
JP7496206B2 (en) Oil-in-water emulsion composition
JP4275872B2 (en) Mixing topical skin composition for use
EP4349320A1 (en) Multilayer emulsion cosmetic composition

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication